Menu Search
Equities

GE Healthcare Technologies Inc

L0T:HAN

GE Healthcare Technologies Inc

Actions
  • Price (EUR)79.45
  • Today's Change0.55 / 0.70%
  • Shares traded1.00
  • 1 Year change+21.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

  • Revenue in USD (TTM)19.56bn
  • Net income in USD1.68bn
  • Incorporated2022
  • Employees51.00k
  • Location
    GE Healthcare Technologies Inc500 West Monroe StreetCHICAGO 60661United StatesUSA
  • Phone+1 (203) 360-4369
  • Fax+1 (302) 655-5049
  • Websitehttps://www.gehealthcare.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		GEHC:NSQ since
announced		Transaction
value
MIM Software IncDeal completed08 Jan 202408 Jan 2024Deal completed9.87%--
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.